Clinical Trial Update: A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial assesses the safety, dosing, and delivery of NEO100 in pediatric brain and CNS tumors and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Choroid Plexus Carcinoma
• Diffuse Midline Glioma H3 K27m-mutant
• High-grade Glioma
• Pineocytoma
• Spinal Cord Tumor

Drugs mentioned

• NEO100

Snippet

Sponsor: Neonc Technologies, Inc. | Conditions: Pediatric Tumor of CNS, Pediatric Tumor of Brain | Phase 1 | Status: NOT_YET_RECRUITING